Picture of Aptinyx logo

APTX — Aptinyx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

U.S. STOCKS ON THE MOVE-Target, Chevron, Zoom

* 
      Eikon search string for individual stock moves:  STXBZ 
    

        * 
      The Day Ahead newsletter: https://refini.tv/3LI4BU7
    

        * 
      The Morning News Call newsletter: https://refini.tv/3dKUyB8
    

  
U.S. stock index futures reversed early losses on Tuesday, pointing to another
day of relief rally on Wall Street even as Treasury yields climbed on bets of
more interest rate hikes from the Federal Reserve. .N 
    
    At 7:50 ET, Dow e-minis  1YMc1  were up 0.26% at 32,993. S&P 500 e-minis
 ESc1  were up 0.32% at 4,000.75, while Nasdaq 100 e-minis  NQc1  were up 0.41%
at 12,132.25.
 
 The top three NYSE percentage gainers premarket  .PRPG.NQ :
 ** Hims & Hers Health Inc HIMS.N , up 9.2%
 ** Shift4 Payments Inc  FOUR.N , up 9.2%
 ** Kontoor Brands Inc KTB.N , up 7.6%
 
 The top three NYSE percentage losers premarket  .PRPL.NQ :
 ** Baytex Energy Corp  BTE.N , down 10.2%
 ** Ameresco Inc  AMRC.N , down 8.7%
 ** Owens & Minor Inc  OMI.N , down 7%
 
 The top Nasdaq percentage gainer premarket  .PRPG.O 
 ** Catalyst Biosciences Inc CBIO.O , up 59.2%
 
 The top Nasdaq percentage loser premarket  .PRPL.O :
 ** Aptinyx, Inc  APTX.O , down 67.3%
 
 
 ** Target Corp  TGT.N : up 1.3% premarket
 BUZZ - Up on posting surprise rise in Q4 sales  urn:newsml:reuters.com:*:nL4N358330 

 ** Zoom Video Communications Inc  ZM.O : up 7% premarket
 BUZZ - Climbs on upbeat annual profit view, two brokerages raise PT
 urn:newsml:reuters.com:*:nL4N3582OL 
    
 ** Carvana Co  CVNA.N : down 0.3% premarket
 BUZZ - Jefferies cuts Carvana's PT citing headwinds to used car sales
 urn:newsml:reuters.com:*:nL4N3582V3 
    
 ** Chevron Corp  CVX.N : up 1.4% premarket
 BUZZ - Gains on raising annual buyback forecast  urn:newsml:reuters.com:*:nL4N3582Y0 
    
 ** Aptinyx Inc  APTX.O : down 67.3% premarket
 BUZZ - Falls on dementia drug failing mid-stage study, PTSD drug termination
 urn:newsml:reuters.com:*:nL4N35832F 

 (Compiled by Rajarshi Roy and Pratyush Thakur)
 ((Pratyush.Thakur@thomsonreuters.com))

Recent news on Aptinyx

See all news